Prosthetic Heart Valve Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2022 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Prosthetic Heart Valve Market: By Type (Biological Heart Valves, Mechanical Heart Valves, and Transcatheter Heart Valves) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Prosthetic Heart Valve Market size was valued at USD 6,815.2 million in 2021 and is poised to grow at a significant CAGR of 11.9% over 2022–2028. The four chambers of the human heart each have a valve to guarantee that blood only flows in one direction. The blood flows back into the atria or ventricles if any of the heart valves are leaking, constricted, swollen, or ruptured, placing extreme strain on the entire heart. The worst-case scenario here could result in arrhythmia or possibly heart failure. Prosthetic heart valves can be installed to fix the issue, depending on the defect’s severity. Due to the aging population, lack of physical activity, and bad diet, demand for this sort of surgery is predicted to increase dramatically over the next few decades in many regions worldwide. In 2050, around 850,000 people will need mechanical heart valves. Furthermore, according to the World Health Organization, about 2% of patients with cardiovascular diseases (CVDs) have rheumatic heart disorders. Therefore, the market is projected to benefit in the years to come from the rise of rheumatic heart disorders. Additionally, the hunt for an alternative to the replacement heart valves already in use began in 2019 by researchers at ETH Zurich and the South African business SAT. And with some success: they designed a silicone prosthetic heart valve that is produced using 3D printers in several processes.

Prosthetic Heart Valve Market

MARKET SUMMARY
-
11.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 11.9%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Prosthetic Heart Valve Market

  • The report on global prosthetic heart valve market gives historical, current and future market sizes (US$ Mn) on the basis of product type, and geography.
  • The prosthetic heart valve market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • LivaNova
  • Symetis
  • Jenavalve Technology
  • Cryolife
  • TTK Healthcare Limited
Prosthetic Heart Valve Market Dynamics

Several healthcare facilities are using new and enhanced technology to give patients better therapies, drugs, and treatments since the healthcare system is rapidly evolving. Numerous government initiatives strongly support these advancements. The Prosthetic heart valve market is expanding, and this trend is projected to continue due to various payment methods and flexible insurance claims. Furthermore, data is crucial for properly developing and designing heart valves. Players in the market create the highest caliber valves with vital hospital data. Manufacturers are creating smart and intelligent heart valves using data-driven technologies like the Internet of Things and Prosthetic intelligence. In the upcoming years, market growth is anticipated to be driven by the swift adoption of data-driven technologies. However, the Prosthetic valve’s high price and risk associated with replacement may constrain the market.


North-America Got Significant Share

Prosthetic Heart Valve Market

The prosthetic heart valve market in North America is likely to hold a significant revenue share in 2021, and in the following years, it is predicted to increase rapidly. This is due to prominent players operating in these nations, a well-developed healthcare infrastructure, attractive reimbursement regulations, and other factors. Additionally, it is anticipated that rising expansion activities through strategic mergers and acquisitions for customer base expansion and technical developments would further boost the growth of the target market in this area.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The prosthetic heart valve market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Prosthetic Heart Valve Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The prosthetic heart valve market is projected to expand at a CAGR of 11.9% during the forecast period

Edwards Lifesciences, Medtronic, Abbott, Boston Scientific Corporation, LivaNova, Symetis, Jenavalve Technology

North America is the fastest-growing region for prosthetic heart valve market


Report

Company Profile

  • Edwards Lifesciences
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • LivaNova
  • Symetis
  • Jenavalve Technology
  • Cryolife
  • TTK Healthcare Limited
  • Colibri Heart Valve
  • Lepu Medical Technology
  • Braile Biomédica
  • Micro Interventional

Description

Prosthetic Heart Valve Market size was valued at USD 6,815.2 million in 2021 and is poised to grow at a significant CAGR of 11.9% over 2022–2028. The four chambers of the human heart each have a valve to guarantee that blood only flows in one direction. The blood flows back into the atria or ventricles if any of the heart valves are leaking, constricted, swollen, or ruptured, placing extreme strain on the entire heart. The worst-case scenario here could result in arrhythmia or possibly heart failure. Prosthetic heart valves can be installed to fix the issue, depending on the defect’s severity. Due to the aging population, lack of physical activity, and bad diet, demand for this sort of surgery is predicted to increase dramatically over the next few decades in many regions worldwide. In 2050, around 850,000 people will need mechanical heart valves. Furthermore, according to the World Health Organization, about 2% of patients with cardiovascular diseases (CVDs) have rheumatic heart disorders. Therefore, the market is projected to benefit in the years to come from the rise of rheumatic heart disorders. Additionally, the hunt for an alternative to the replacement heart valves already in use began in 2019 by researchers at ETH Zurich and the South African business SAT. And with some success: they designed a silicone prosthetic heart valve that is produced using 3D printers in several processes.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX